Press release
Subcutaneous Drug Delivery Market CAGR of 9.7% To Reach US$ 17,445.9 Million By 2027 | Novo Nordisk A/S, Johnson & Johnson,
๐๐ฅ๐จ๐๐๐ฅ ๐๐ฎ๐๐๐ฎ๐ญ๐๐ง๐๐จ๐ฎ๐ฌ ๐๐ซ๐ฎ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญGlobal Subcutaneous Drug Delivery Market according to a recent study released by Coherent Market Insights, the market is projected to be worth US$ 9,111.6 million in 2020, with a CAGR of 9.7% over the projection period (2020-2027).
Prefilled syringes are plastic syringes of premeasured dose that are ready to use. It improves patient compliance, dosing accuracy, usability, and protection while lowering dosing errors. Healthcare practitioners are increasingly using combination devices, especially injectable drug delivery systems such as prefilled syringes, as the number of injectable biological drugs grows.
According to Fisher Clinical Service's report, "Growth and Benefits of Pre-Filled Syringes," about 13 biotechnology drugs were commercially available in 1989, rising to 210 in 2012. According to Fisher Clinical Service, the prefilled syringes market was projected to account for a quarter of all injectable drug delivery systems in 2013 which included around 35 of the 100 top-selling drugs, which were to be incorporated in the form of injection.
In April 2020, Teva Pharmaceuticals USA, Inc. dispatched the autoinjector gadget for AJOVY (fremanezumab-vfrm) injection in the U.S. market. AJOVY is shown for the preventive treatment of migraine in adults and is offered subcutaneously to the patients. Likewise, in December 2016, Becton, Dickinson and Company declared the dispatch of BD Neopak 2.25 mL prefillable glass needle, which is produced for biopharmaceutical makers zeroed in on assembling of touchy biologic medications for the therapy of ongoing sicknesses like rheumatoid joint inflammation, psoriasis, lupus, and serious asthma. The needle offers higher volume subcutaneous injections, in this manner assisting with improving security and comfort for patients.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/2933
๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐จ๐ซ๐จ๐ง๐๐ฏ๐ข๐ซ๐ฎ๐ฌ (๐๐จ๐ฏ๐ข๐-๐๐) ๐๐๐ง๐๐๐ฆ๐ข๐:
โข The pandemic of COVID-19 has had a major impact on clinical trials. According to a survey conducted on April 23, 2020 by Medidata Solutions, Inc. (an American technology firm that produces and markets applications as a service for clinical trials), 63 percent of survey respondents have avoided hiring new patients for existing clinical trials, while 43 percent have delayed their studies.
โข Additionally, in March 2020, the US Food and Drug Administration (FDA) issued recommendations for administering clinical testing of medicinal drugs during the COVID-19 public health emergency. On June 3, 2020, the recommendations were revised again.
โข Clinical trials for the treatment of COVID-19 are being conducted by research institutes by delivering possible medicines subcutaneously.
โข For example, on April 13, 2020, the University Hospital of La Princesa began a phase 2 clinical trial to assess the safety and effectiveness of Sarilumab delivered subcutaneously for the treatment of COVID-19. The research will be finished in June 2020.
โข Furthermore, healthcare institutions and researchers are conducting current clinical trials using the following safety precautions:
โข Patients' approval is obtained over the internet or via video calls by healthcare providers. According to a survey conducted on April 23, 2020 by Medidata Solutions, Inc., 45 percent of respondents choose virtual/telemedicine for consulting.
โข Before scheduling in-person appointments, patients get a phone call to check for COVID-19 symptoms.
โข Study evaluations are carried out in isolated outpatient settings.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/2933
In order to broaden their product offerings in the industry, key players are focusing on implementing numerous inorganic growth initiatives such as partnership alliances, and agreements. Insulet Corporation, for example, announced an agreement with a dealer in May 2019 of its Omnipod System in Finland, Italy, Norway, Sweden and other European countries.
In addition, small businesses are concentrating on the production of novel epinephrine auto injectors that are thermally stable. Manufacturers in the global subcutaneous drug delivery industry have a growth potential because currently available drugs perform well at particular temperatures. For patients suffering from anaphylaxis due to an acute allergic attack, Windgap Medical is working on a handheld kit that can blend a dry version of the drug into solution, allowing temperature consistency and a longer shelf-life of treatment.
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ:
Due to increased product releases and approvals, the global subcutaneous drug delivery market is projected to develop at a CAGR of 9.7% over the forecast period. For example, Becton, Dickinson and Company obtained FDA approval for the second generation BD Nano pen needle in January 2019, which is designed for more accurate subcutaneous injection in diabetic patients.
Because of the substantial rise in self-administration of medications to cure chronic disorders, the disposable segment is projected to have a larger market share in 2020.
Because of the increasing prevalence of autoimmune diseases such as multiple sclerosis and new approvals for injector implants, the auto-immune disorders segment held a higher market share among disease indications in 2018.
๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
โข ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฎ๐๐๐ฎ๐ญ๐๐ง๐๐จ๐ฎ๐ฌ ๐๐ซ๐ฎ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ, ๐๐ฒ ๐๐ฌ๐๐๐ข๐ฅ๐ข๐ญ๐ฒ:
o Disposable
o Reusable
โข ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฎ๐๐๐ฎ๐ญ๐๐ง๐๐จ๐ฎ๐ฌ ๐๐ซ๐ฎ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ, ๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ง๐๐ข๐๐๐ญ๐ข๐จ๐ง:
o Auto-immune Disorders
o Neurological Disorders
o Oncology Disorders
o Hormonal Disorders
o Allergy & Infectious Disorders
o Ophthalmic Disorders
o Others
โข ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฎ๐๐๐ฎ๐ญ๐๐ง๐๐จ๐ฎ๐ฌ ๐๐ซ๐ฎ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ, ๐๐ฒ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐ฒ๐ฉ๐:
o Prefilled Syringe
o Autoinjector
o Spring Type
o Motorized Type
o Wearable Type
o Prefilled Pen
o Disposable
o Reusable
o Vial (Syringe)
o Pump and Others
โข ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฎ๐๐๐ฎ๐ญ๐๐ง๐๐จ๐ฎ๐ฌ ๐๐ซ๐ฎ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ, ๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
๐๐จ ๐๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ https://www.coherentmarketinsights.com/insight/request-pdf/2933
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Subcutaneous Drug Delivery Market CAGR of 9.7% To Reach US$ 17,445.9 Million By 2027 | Novo Nordisk A/S, Johnson & Johnson, here
News-ID: 2542783 • Views: โฆ
More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb โฆ
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growthโฆ

Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion โฆ
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, businessโฆ

Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by โฆ
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,โฆ

Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni โฆ
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,โฆ
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcomingโฆ
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De โฆ
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeuticโฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric โฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550โฆ
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โAlcohol Testing And Drug Testing Equipment marketโ, detailing every single market driver and intricately analyzing the business vertical. This โAlcohol Testing And Drug Testing Equipment marketโ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drugโฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymeraseโฆ